Chronic heart failure
Conditions
Interventions
Control Group:routine treatment care
Experimental Group:Implement cudgel acupuncture intervention based on the control group.
Sponsors
Chengdu University of Traditional Chinese Medicine Affiliated Hospital
Eligibility
Sex/Gender
All
Age
45 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Meets the diagnostic criteria for CHF; (2) Meets the diagnostic criteria for deficiency of both qi and yin in traditional Chinese medicine; (3) Age between 45 and 75 years old; (4) Cardiac function classified as Grade II-III; (5) PSQI > 7 points; (6) Voluntarily participates in this study and signs the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Patients with severe primary cardiogenic diseases such as cardiogenic shock, second-degree or higher atrioventricular block, and life-threatening arrhythmias; (2) Patients with primary diseases involving abnormal liver or kidney function, or dysfunction of the digestive, endocrine, or hematopoietic systems; (3) Patients with severe bleeding tendencies or platelet count (PLT) < 50×10^9/L; (4) Diseases or symptoms associated with high mortality, such as acute myocardial infarction, cerebral hemorrhage, cardiac tamponade, severe constrictive pericarditis, or pulmonary embolism; (5) Patients undergoing other treatments that may affect the evaluation of sleep improvement (e.g., sedative-hypnotic drugs); (6) Women in pregnancy or lactation; (7) Patients with skin integrity compromised at the treatment site, such as eczema, scabies, or ulceration; (8) Patients with severe psychological disorders, mental illnesses, or cognitive impairments; (9) Patients currently participating in other clinical trials. (Note: Participants meeting any one of the above criteria will be excluded.)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pittsburgh Sleep Quality Index (PSQI) Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Insomnia Severity Index (ISI) Score;Hospital Anxiety and Depression Scale (HADS) Score;Minnesota Living with Heart Failure Questionnaire (MLHFQ) score;N-terminal pro-B-type natriuretic peptide level; | — |
Countries
China
Contacts
Public ContactFeng Juan
Hospital of Chengdu University of Traditional Chinese Medicine
Outcome results
None listed